Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 05 2020
Historique:
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 27 10 2020
Statut: epublish

Résumé

The role of surgery in early-stage cervical cancer has been established, but it is controversial in locally advanced cervical cancer. To determine whether a radical hysterectomy method with extended removal of paracervical tissue for locally advanced cervical cancer is associated with satisfactory oncological outcomes. This retrospective cohort study was conducted from January 1, 2002, to December 31, 2011, and participants were patients with cervical cancer at a single tertiary center in Northern Japan. The median follow-up period was 106 months, and none of the patients were lost to follow-up at less than 60 months. Data analyses were performed from July 1, 2017, to December 31, 2018. Patients underwent radical hysterectomy using the Okabayashi-Kobayashi method. Bilateral nerve preservation was used for stage IB1/IB2 disease and unilateral nerve preservation for stage IIA/IIB if disease extension outside the uterine cervix was 1-sided. Chemotherapy was used as the choice of adjuvant treatment for patients with an intermediate or high risk of recurrence, while some patients chose or were assigned to radiotherapy. Primary outcomes were the 5-year local control rate and 5-year overall survival rate along with risk factor analysis. Of 121 consecutive patients, 76 (62.8%) had early-stage cervical cancer in 2008 International Federation of Gynecology and Obstetrics stages IB1 and IIA1 and 45 (37.2%) had locally advanced cervical cancer in stages IB2, IIA2, and IIB. The median (range) age was 42 (26-68) years. Adjuvant radiotherapy was used in 2 patients (3%) with early-stage cervical cancer and 3 (7%) of those with locally advanced cervical cancer. The 5-year local control rates for early-stage cervical cancer and locally advanced cervical cancer were 99% and 87%, respectively. The 5-year overall survival rates for early-stage cervical cancer and locally advanced cervical cancer were 95% and 82%, respectively. Cox regression analysis showed that lymph node metastasis and histology of adeno(squamous)carcinoma were independent risk factors for the overall survival of patients with cervical cancer treated with radical hysterectomy. The nerve-sparing Okabayashi-Kobayashi radical hysterectomy for locally advanced cervical cancer may provide survival not inferior to radical hysterectomy or radiotherapy in published literature. The applicability of radical hysterectomy with adjuvant chemotherapy for locally advanced cervical cancer needs to be validated by prospective comparative trials.

Identifiants

pubmed: 32379332
pii: 2765657
doi: 10.1001/jamanetworkopen.2020.4307
pmc: PMC7206506
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e204307

Références

Int J Gynecol Cancer. 2018 Oct;28(8):1560-1568
pubmed: 30247249
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):995-1001
pubmed: 16343175
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S43-103
pubmed: 17161167
J Clin Oncol. 2005 Oct 20;23(30):7428-36
pubmed: 16234510
Gynecol Oncol. 2016 Jul;142(1):109-114
pubmed: 27179979
Int J Gynaecol Obstet. 2009 May;105(2):103-4
pubmed: 19367689
Gynecol Oncol. 1996 Aug;62(2):139-47
pubmed: 8751541
Obstet Gynecol. 1978 Aug;52(2):138-45
pubmed: 683652
Gynecol Oncol. 2007 Oct;107(1):4-13
pubmed: 17905140
Obstet Gynecol. 1974 Aug;44(2):265-72
pubmed: 4417035
Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):27-32
pubmed: 28195087
Ann Transl Med. 2019 May;7(9):203
pubmed: 31205921
Surg Radiol Anat. 1991;13(1):17-22
pubmed: 2053040
Int J Clin Oncol. 2019 Jan;24(1):1-19
pubmed: 30291468
Stat Med. 1999 Mar 30;18(6):695-706
pubmed: 10204198
Eur J Gynaecol Oncol. 2006;27(6):553-60
pubmed: 17290582
J Gynecol Oncol. 2020 May;31(3):e49
pubmed: 32266799
Am J Obstet Gynecol. 1951 Oct;62(4):854-70
pubmed: 14885271
J Gynecol Oncol. 2018 May;29(3):e41
pubmed: 29533024
Gynecol Oncol. 2004 May;93(2):429-34
pubmed: 15099957
Obstet Gynecol. 2019 Jun;133(6):1086-1098
pubmed: 31135722
Int J Gynecol Cancer. 2017 Feb;27(2):350-356
pubmed: 27984376
Gynecol Oncol. 2005 May;97(2):387-94
pubmed: 15863134
Cancer Manag Res. 2018 Nov 19;10:5927-5935
pubmed: 30510460
Gynecol Oncol. 2017 Aug;146(2):292-298
pubmed: 28526168
Int J Gynecol Cancer. 2005 Mar-Apr;15(2):389-97
pubmed: 15823132
J Obstet Gynaecol Res. 2019 Feb;45(2):289-298
pubmed: 30426591
Gynecol Obstet Invest. 1981;12(6):281-93
pubmed: 7297937
Baillieres Clin Obstet Gynaecol. 1988 Dec;2(4):953-62
pubmed: 3229063
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84
pubmed: 30659131
Onco Targets Ther. 2018 Sep 19;11:5527-5533
pubmed: 30275701
Gynecol Oncol. 2009 Jul;114(1):69-74
pubmed: 19398126
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645

Auteurs

Noriaki Sakuragi (N)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Department of Gynecology, Otaru General Hospital, Otaru, Japan.

Tatsuya Kato (T)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Chisa Shimada (C)

Department of Gynecology, Hokkaido Cancer Center, Sapporo, Japan.

Masanori Kaneuchi (M)

Department of Gynecology, Otaru General Hospital, Otaru, Japan.

Yukiharu Todo (Y)

Department of Gynecology, Hokkaido Cancer Center, Sapporo, Japan.

Takashi Mitamura (T)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Mahito Takeda (M)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Masataka Kudo (M)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Gen Murakami (G)

Department of Anatomy II, Sapporo Medical University, Sapporo, Japan.
Division of Internal Medicine, Jikou-kai Clinic of Home Visits, Sapporo, Japan.

Hidemichi Watari (H)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH